(Q30497303)

English

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

scientific article published on September 25, 2010

Statements

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer (English)
Basmina Parmakhtiar
Patrick Connelly

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit